首页 | 本学科首页   官方微博 | 高级检索  
检索        

7种蛇毒小肽对临床分离耐(多)药结核分枝杆菌的体外活性研究
引用本文:谢建平,乐军,熊郁良,王婉瑜,于善谦,王洪海.7种蛇毒小肽对临床分离耐(多)药结核分枝杆菌的体外活性研究[J].中国药学杂志,2003,38(5):384-385.
作者姓名:谢建平  乐军  熊郁良  王婉瑜  于善谦  王洪海
作者单位:1. 复旦大学生命科学学院,上海,200433;西南师范大学现代生物医药研究所生命科学学院,重庆,400715
2. 复旦大学生命科学学院,上海,200433;上海市肺科医院,上海,200433
3. 中国科学院昆明动物研究所动物毒素研究室,云南,昆明,650223
4. 复旦大学生命科学学院,上海,200433
摘    要: 目的检测7种从蛇毒分离的小肽是否对临床分离的耐药性结核分枝杆菌菌株具有活性。方法放射性方法检测蛇毒小肽对结核分枝杆菌的最小抑制浓度,细菌存活计数确证放射性方法的结果。结果7种蛇毒小肽对耐药性结核分枝杆菌菌株都有活性。其MIC值分别为(μg·mL-1):Opiophagus hannah 5.4,Naja atra 8.6,Bungarus fasciatus 6.4,Trimeresurus stejnegri 12.6,Protobothrops mucrosquamatus 11.8,Protobothrops jerdonii 7,Agksistrodon halys 4.2。结论这些结果是首次报道,为进一步设计和开发新来源的抗结核病新药提供了依据。

关 键 词:耐药性  结核分枝杆菌  蛇毒  药物开发
文章编号:1001-2494(2003)05-0384-02
收稿时间:2002-01-20;
修稿时间:2002年1月20日

In Vitro activities of seven small peptides from snake venoms against clinical (multi)drug-resistant Mycobacterium tuberculosis isolates
XIE Jian ping ,YUE Jun ,XIONG Yu liang ,WANG Wan yu ,YU Shan qian ,WANG Hong hai.In Vitro activities of seven small peptides from snake venoms against clinical (multi)drug-resistant Mycobacterium tuberculosis isolates[J].Chinese Pharmaceutical Journal,2003,38(5):384-385.
Authors:XIE Jian ping    YUE Jun    XIONG Yu liang  WANG Wan yu  YU Shan qian  WANG Hong hai
Institution:XIE Jian ping 1,4,YUE Jun 1,3,XIONG Yu liang 2,WANG Wan yu 2,YU Shan qian 1,WANG Hong hai 1*
Abstract:OBJECTIVE To determine whether the 7 small peptides isolated from snake venoms possess activities against clinical isolated multidrug resistant strains of Mycobacterium tuberculosis.METHOD S The MICs of the small peptides were determined by radiometric,and confirmed by bacterial viable count.RESULTS All seven tested small peptides showed activities against the above strains.The MIC values were (unit:μg·mL-1) Opiophagus hannah 5.4,Naja atra 8.6,Bungarus fasciatus 6.4,Trimeresurus stejnegri 12.6,Protobothrops mucrosquamatus 11.8,Protobothrops jerdonii 7,Agksistrodon halys 4.2,respectivly.CONCLUSION The results provided a basis for further developing novel anti-mycobacterial agents and improving treatment of tuberculosis.
Keywords:drug resistance  Mycobacterium tuberculosis  snake toxin  drug development
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号